| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.035 | 0.5 |